# The Vital Role of Family Physicians in the Screening and Early Detection of Lynch Syndrome: A Case Report

**Authors:** José Campelos, Maria Gomes, Alexandra Campos, Maria Cardoso, Mariana Lopes

PMC · DOI: 10.7759/cureus.102547 · Cureus · 2026-01-29

## TL;DR

A family physician's early detection of Lynch syndrome through genetic testing and thorough screening led to timely cancer treatment and preventive surgeries.

## Contribution

Highlights the importance of family physicians in identifying hereditary cancer syndromes using genograms and appropriate screening.

## Key findings

- A pathogenic MLH1 gene variant was identified, confirming Lynch syndrome in a patient with a strong family history of colorectal cancer.
- Early detection led to segmental colectomy and prophylactic surgeries to prevent further malignancies.
- The case emphasizes the role of family physicians in managing hereditary cancer risks and coordinating multidisciplinary care.

## Abstract

Lynch syndrome (LS) is an autosomal dominant disorder associated with an increased risk of colorectal, endometrial, and other malignancies. This report describes the case of a 53-year-old female patient with a significant family history of colorectal cancer. She presented with metrorrhagia and iron deficiency anemia. Given her strong familial cancer history, besides the transvaginal ultrasound, a colonoscopy was performed despite a recent normal result. The new colonoscopy revealed a vegetative and ulcerated neoplasm at the rectosigmoid junction, confirmed as adenocarcinoma by biopsy. Genetic testing identified a pathogenic MLH1 gene variant (c.2041G>A p.Ala681Thr), confirming LS. The patient was referred for Oncology, Gastroenterology, Surgery, and Genetics consultations. A segmental colectomy was performed along with prophylactic surgery, including hysterectomy and salpingo-oophorectomy. This case highlights the vital role of family physicians in recognizing hereditary cancer syndromes, utilizing genograms to expedite diagnosis, and ensuring proper screening for associated extracolonic malignancies in affected families.

## Linked entities

- **Genes:** MLH1 (mutL homolog 1) [NCBI Gene 4292]
- **Diseases:** Lynch syndrome (MONDO:0005835), colorectal cancer (MONDO:0005575), endometrial cancer (MONDO:0002447), adenocarcinoma (MONDO:0004970), iron deficiency anemia (MONDO:0001356)

## Full-text entities

- **Genes:** MSH6 (mutS homolog 6) [NCBI Gene 2956] {aka GTBP, GTMBP, HNPCC5, HSAP, LYNCH5, MMRCS3}, PMS2 (PMS1 homolog 2, mismatch repair system component) [NCBI Gene 5395] {aka HNPCC4, LYNCH4, MLH4, MMRCS4, PMS-2, PMSL2}, MSH2 (mutS homolog 2) [NCBI Gene 4436] {aka COCA1, FCC1, HNPCC, HNPCC1, LCFS2, LYNCH1}, MLH1 (mutL homolog 1) [NCBI Gene 4292] {aka COCA2, FCC2, HNPCC, HNPCC2, LYNCH2, MLH-1}
- **Diseases:** endometrial and ovarian cancers (MESH:D004714), hypertension (MESH:D006973), colorectal, endometrial, and other extracolonic malignancies (MESH:D016889), HNPCC (MESH:D015179), autosomal dominant disorder (MESH:D030342), iron deficiency anemia (MESH:D018798), LS (MESH:D003123), obesity (MESH:D009765), fatigue (MESH:D005221), metrorrhagia (MESH:D008796), Adenocarcinoma (MESH:D000230), cancer (MESH:D009369), dyslipidemia (MESH:D050171), hereditary cancer (MESH:D009386)
- **Chemicals:** alcohol (MESH:D000438), amlodipine (MESH:D017311), perindopril (MESH:D020913)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** p.Ala681Thr

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12949529/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12949529/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12949529/full.md

---
Source: https://tomesphere.com/paper/PMC12949529